News Headlines
-
Tonix Pharmaceuticals Announces Selection Of Two Contract Manufacturing Organizations For The Launch And Commercial Manufacture Of Tonmya™ For The Management Of Fibromyalgia
3/20/2024
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced it has selected two contract manufacturing organizations (CMOs), one of which is Almac Pharma Services, a member of the privately owned Almac Group, as dual supply sources for the potential launch and commercialization of Tonmya™ (also known as TNX-102 SL, cyclobenzaprine HCl sublingual tablets) in the U.S.
-
Partnership Agreement Between Croda And AAHI To Drive Innovation In Vaccine Development
3/19/2024
Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and development of adjuvant formulations, under which Croda and AAHI will leverage their combined expertise to make novel vaccine adjuvant formulations globally accessible, thereby advancing next generation, robust and durable vaccines.
-
Terumo Blood And Cell Technologies Partners With CiRA Foundation To develop Automated iPS Cell Manufacturing
3/19/2024
Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, and CiRA Foundation, a public interest organization for the transfer of induced pluripotent stem (iPS) cells to industry, today announced a partnership designed to propel the broad use of iPS cells for a range of new therapies.
-
White Raven Increases Manufacturing Efficiency And Flexibility With Aseptic Filling From Cytiva
3/19/2024
White Raven, a contract development and manufacturing organization (CDMO) specializing in formulation and aseptic filling, has chosen global life science leader, Cytiva for its aseptic filling needs. Cytiva's SA25 Aseptic Filling Workcell will complete White Raven’s comprehensive drug product platform, offering substantial flexibility to meet customers' manufacturing and development needs.
-
AstraZeneca To Acquire Fusion To Accelerate The Development Of Next-Generation Radioconjugates To Treat Cancer
3/19/2024
AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).
-
Hovione And GEA Strengthen Partnership To Advance Continuous Tableting Technology
3/19/2024
Hovione, the specialist integrated CDMO and leader in spray drying and particle engineering, and GEA, a global leader in process technology for the pharmaceutical industry, today announced the next stage of their partnership, with new development agreements, the launch of the ConsiGma CDC flex as well as the installation of a new lab-scale R&D Continuous Tableting rig in Hovione´s facilities in Portugal.
-
Scorpius Holdings Awarded Contract In Excess Of $1M With NIH-Funded Researcher At A Major University
3/19/2024
Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing organization (CDMO), today announced that it has been awarded a contract in excess of $1 million with an NIH-funded researcher at a major university.
-
WuXi Biologics Breaks Ground On CRDMO Center In Singapore
3/19/2024
WuXi Biologics (“WuXi Bio”) a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has broken ground on its new 13.5-hectare CRDMO center in Tuas Biomedical Park, Singapore.
-
SCHOTT Pharma To Expand In The U.S. With New Prefillable Syringe Manufacturing Facility In Wilson, North Carolina
3/18/2024
SCHOTT Pharma, a pioneer in pharmaceutical drug containment solutions and delivery systems, will build the first U.S. facility to manufacture prefillable polymer syringes required to meet the need for deep-cold storage and transportation of mRNA medications.
-
Kindeva Drug Delivery Welcomes Jennifer Riter, New Vice President of Analytical Services
3/18/2024
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today welcomes Jennifer Riter as Vice President of Analytical Services to head up the recently announced analytical services global business unit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240318401921/en/ Jennifer Riter joins Kindeva Drug Delivery as Vice President of Analytical Services to lead new analytical services business unit. (Photo: Business Wire) Riter comes to Kindeva from West Pharmaceutical where she